MDSCs derived from myeloid cells suppress the immune system in the TME by inducing apoptosis of CD8+ T cells, releasing immunosuppressive cytokine TGF-β, and releasing VEGF to promote tumor angiogenesis. The gene discussed is CD8A; the disease is neoplasm.